Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Abstract 4988: FOXP3, a Critical Mediator of Regulatory T-cell Function, is Expressed in Subsets of Myeloid Cells.

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

Foxp3 Post-translational Modifications and Treg Suppressive Activity

FOXP3 and its role in the immune system

FoxP3 in T<sub>reg</sub> cell biology: a molecular and structural perspective

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

FoxP3 in T reg cell biology: a molecular and structural perspective

FOXP3 exon 2 controls T reg stability and autoimmunity

The regulation of immune tolerance by FOXP3

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

FOXP3 and Its Partners: Structural and Biochemical Insights into the Regulation of FOXP3 Activity

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

FoxP3 in Treg Cell Biology: a Molecular and Structural Perspective

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

FOXP3+ Tregs: Heterogeneous Phenotypes and Conflicting Impacts on Survival Outcomes in Patients with Colorectal Cancer

Is Foxp3 Still a Specific Marker for Regulatory T Cells in Human

Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation

Regulatory T Cells: the Many Faces of Foxp3

Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function